Cue Biopharma (CUE) News
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.15-0.35 (-7.78%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CUE news summary
We found 2 recent headlines mentioning Cue Biopharma (CUE): 2 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. CUE is making an outsized move today, down 7.78% at $4.15, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Biotech Stocks On The Rise - AKAN +88%, CUE +49%, ADAG +24%, ANTX +23%, NRXP +10%", was published by Nasdaq on Nov 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Cue Biopharma headlines
- Biotech Stocks On The Rise - AKAN +88%, CUE +49%, ADAG +24%, ANTX +23%, NRXP +10%(RTTNews) - Shares of several biotech and healthcare companies moved higher amid clinical updates, quarterly results and increased trading activity. Akanda and Adagene rallied without fresh…NasdaqADAG, AKAN, ANTX, CUE
- Cue Biopharma Reports Third Quarter 2026 Financial Results and Recent Business HighlightsBOSTON, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, today reported…GlobeNewswire